Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Is the chief pharmaceutical officer of England serving patients and the profession well?

Upon his appointment in 2005, the chief pharmaceutical officer for England Keith Ridge stated that: “Over the past few years, patients have demanded change to how health services are delivered, including pharmacy. The Government and the pharmacy profession have listened and are responding, putting pharmacy practitioners right at the front line of patient care. Prescribing of medicines by pharmacists and the new community pharmacy contract will increase access to healthcare. I intend to help make sure patients benefit from these and other initiatives.” (The Pharmaceutical Journal online, 3 December 2005)

Since taking up his role in March 2006, does Ridge think he has been successful in making sure patients are benefiting from his work? Does he think that he has represented the entire profession, from those in academia and industry to those in hospitals, general practices and community pharmacies? Does he have examples as to how he has furthered each of these sectors?

How does he feel that the government’s proposal to reduce pharmacy funding, and reduce the community pharmacy network by up to 3,000 pharmacies, will “[put] pharmacy practitioners right at the front line of patient care” and “increase access to healthcare” given that the aim seems to be to move toward centralised dispensing (aka “Amazonisation”) and removal of healthcare professionals from the very places they are needed? Or is he still of the belief that “there are too many community pharmacies” as stated in 2013 (Chemists & Druggist, 7 November 2013)?

Does he think community pharmacy is an appropriate place for a pharmacist independent prescriber to be practising their skills, e.g. in management of long-term condition or treatments of minor ailments? Is he in agreement with the All-Party Pharmacy Group that all pharmacists should be able to train to become prescribers by 2022 (The Pharmaceutical Journal online, 27 April 2017)? If he has any doubts, I would be delighted to introduce him to any of the countless numbers of patients who have avoided a long wait to see their GP or trip to accident and emergency in the NHS Cumbria service running for over two years now.

Ben Merriman

Barrow-in-Furness, Cumbria

NHS England has declined to respond to the letter — Editor.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202812

Readers' comments (2)

  • I agree with you Ben. We can make a real difference to the NHS. Savings can be made so that Community Pharmacy should be the first port of call rather then the GP or A & E. Keith Ridge when is the last time you worked in a community pharmacy are you aware what we are capable of.

    Unsuitable or offensive? Report this comment

  • Graham Phillips

    Maybe The CPhO would care to explain what happened to the NHS' Call to Action for Pharmacy?

    http://psnc.org.uk/the-healthcare-landscape/community-pharmacy-call-to-action/

    http://www.chemistanddruggist.co.uk/news/whatever-happened-nhs-england%E2%80%99s-pharmacy-call-action

    http://www.chemistanddruggist.co.uk/opinion/nhs-call-action-community-pharmacys-watergate

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £21.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • Application and Review of Pediatric Pharmacotherapy

    Application and Review of Pediatric Pharmacotherapy

    Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

    £32.00Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £42.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £37.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.